Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Hepatology (Baltimore, Md.)|December 4, 2003
Thyrotropin-releasing hormone in the dorsal vagal complex stimulates hepatic blood flow in ratsMasashi Yoneda, Takashi Hashimoto, Kimihide Nakamura, et al.
Internal Medicine (Tokyo, Japan)|June 26, 2020
IgG4-related Disease Manifesting as Gastroduodenal Ulcer Diagnosed by an Endoscopic BiopsyOsamu Muto, Susumu Tamakawa, Kenji Takahashi, et al.
Regulatory Peptides|July 26, 2005
Thyrotropin-releasing hormone in the dorsal vagal complex stimulates pancreatic blood flow in ratsMasashi Yoneda, Manabu Goto, Kimihide Nakamura, et al.
European Journal of Pharmacology|February 1, 2003
Central injection of astressin inhibits carbon tetrachloride-induced acute liver injury in ratsYukiomi Nakade, Masashi Yoneda, Shiro Yokohama, et al.
Journal of Gastroenterology|May 29, 2004
High, but not low, molecular weight hyaluronan prevents T-cell-mediated liver injury by reducing proinflammatory cytokines in miceKimihide Nakamura, Shiro Yokohama, Masashi Yoneda, et al.
Hepatology (Baltimore, Md.)|September 24, 2004
Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitisShiro Yokohama, Masashi Yoneda, Masakazu Haneda, et al.
Journal of Hepatology|June 5, 2002
Antithrombin III prevents concanavalin A-induced liver injury through inhibition of macrophage inflammatory protein-2 release and production of prostacyclin in miceKimihide Nakamura, Taku Ito, Masashi Yoneda, et al.
World Journal of Gastroenterology|February 17, 2006
Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitisShiro Yokohama, Yoshihiko Tokusashi, Kimihide Nakamura, et al.
Journal of Gastroenterology|August 14, 2012
Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitisYosui Tamaki, Yukiomi Nakade, Taeko Yamauchi, et al.
Cancer Medicine|November 30, 2021
Prognostic factors to predict the survival in patients with advanced gastric cancer who receive later-line nivolumab monotherapy-The Asahikawa Gastric Cancer Cohort Study (AGCC)Kazuyuki Tanaka, Hiroki Tanabe, Hiroki Sato, et al.
Pageof 3